Transcriptic

Strateos, which came to be through the merger of Transcriptic and 3Scan in 2019, operates a robotic cloud laboratory platform designed to automate life science research. The company was originally founded as Transcriptic in 2012 by Max Hodak and Tim Gardner, both of whom have backgrounds that intersect technology and neuroscience. Hodak, who studied biomedical engineering and worked on brain-machine interfaces, brought a robotics and software perspective to the life sciences. The platform provides on-demand, remote access to a wide array of automated scientific instrumentation, enabling researchers to execute experiments from anywhere in the world. This model serves a diverse client base, including pharmaceutical companies, biotech startups, and academic institutions, by offering a way to accelerate the drug discovery and development process without the need for significant capital investment in in-house laboratories. The business operates on a fee-for-service basis, where clients pay for the specific experiments and lab services they utilize through the company's web-based interface. Researchers can design, control, and monitor their experiments in real-time, with the platform handling everything from sample preparation and cell culture to data acquisition and analysis. This approach allows for greater reproducibility and standardization of experimental results, addressing common challenges in traditional research settings. The integration of 3Scan's high-throughput tissue imaging technology further expanded the platform's capabilities, particularly in the realm of preclinical research.

Keywords: robotic cloud laboratory, life science automation, remote research, drug discovery, biotech services, lab-as-a-service, automated experiments, scientific research platform, preclinical research, cell-based assays